U.S. Infrastructure Stock News

If you are wondering whether Realty Income is fairly priced or offering value right now, this article will walk through what the current numbers are saying about the stock. With the share price at about US$66.14 and total returns of 0.7% over 7 days, 8.9% over 30 days, 15.4% year to date and 22.5% over 1 year, recent moves may have shifted how investors think about both upside and risk. Recent news coverage around Realty Income has largely focused on its role as a large net lease real estate...

Why the new class action matters for uniQure investors Kessler Topaz Meltzer & Check has filed a securities fraud class action against uniQure (NasdaqGS:QURE), alleging misleading statements about FDA alignment and timelines for AMT-130, its Huntington’s disease gene therapy program. See our latest analysis for uniQure. uniQure’s latest share price of US$23.43 comes after a 7 day share price return of 14.29%. However, the 90 day share price return of a 15.66% decline and 5 year total...

Ramaco Resources (METC) has been drawing attention after a sharp decline in its share price over the past month, even as its past 3 months return, one year total return, and longer term performance figures remain positive. See our latest analysis for Ramaco Resources. The recent 40.26% 1 month share price decline to US$16.56 sits against a much stronger backdrop, with a 1 year total shareholder return of 73.74% and multi year total shareholder returns still firmly positive. This suggests...

Orrum Clinical Analytics recently announced a partnership with LivaNova USA Inc. to link LivaNova’s Essenz Perfusion System with Orrum’s CORE Insights platform, enabling automatic transfer of perfusion case data for post-operative analysis and peer benchmarking. By extending Essenz data into a secure analytics environment that supports evidence-based performance improvement, the collaboration could strengthen LivaNova’s positioning in data-driven cardiopulmonary care and potentially appeal...

Earlier this month, International Seaways commented that tightening energy supplies due to sanctions and rising oil demand are reshaping global crude and product shipping patterns, directly affecting its tanker operations. The company highlighted that more complex, longer trade routes could meaningfully influence its operational outlook, potentially altering how it deploys its fleet and prioritizes future opportunities. We'll now examine how management’s views on tightening sanctioned supply...

In February 2026, OPENLANE, Inc. reported full-year 2025 results showing revenue of US$1.93 billion and net income of US$177.7 million, while also recording a basic and diluted loss per share of US$0.96 from continuing operations. The company also issued 2026 guidance calling for income of US$130 million to US$147 million and diluted net income per share of US$0.95 to US$1.09, sharpening investor focus on how its mix of continuing and discontinued operations affects reported...

In February 2026, Housecall Pro announced a new native integration with Yelp, allowing Yelp’s high-intent Request a Quote leads to flow directly into Housecall Pro’s Job Inbox for home service professionals across the U.S. and Canada. A day earlier, Yelp reported fourth-quarter 2025 results showing roughly flat quarterly revenue year over year, alongside full-year revenue growth and new 2026 net revenue guidance of US$1.46–US$1.48 billion as it continues investing in AI-powered...

Consumer Watchdog recently criticized the California Energy Commission for not using its legislative powers to prevent gasoline price spikes after Valero had informed it a year in advance about planned unit shutdowns at the Benicia refinery, which was originally expected to keep operating through April under an agreement. The advocacy group is now urging legislative oversight hearings and new rules on refinery inventories and resupply, putting fresh regulatory attention on Valero’s role in...

Event context and recent performance Hartford Insurance Group (HIG) has drawn fresh investor attention after a recent price move, with the stock closing at $142.19. That sits alongside a 10.6% return over the past month and 4.1% over the past 3 months. See our latest analysis for Hartford Insurance Group. Zooming out, Hartford Insurance Group’s recent 1 day and 1 month share price gains sit against a year to date share price return of 3.7%, while its 1 year total shareholder return is 29.8%...

PharmaPack launch puts Harrow stock in focus Harrow (HROW) has drawn fresh attention after launching PharmaPack, a direct-to-prescriber cash-pay program offering FDA-approved ophthalmic kits intended to replace off-label compounded products used around cataract surgery. See our latest analysis for Harrow. The PharmaPack announcement comes as Harrow’s short term share price momentum is strong, with a 1 month share price return of 16.93% and a 90 day share price return of 26.77%, set against a...

Why Campbell's Stock Is Back in Focus Campbell's (CPB) has drawn fresh attention after its recent name change from Campbell Soup Company to The Campbell's Company, shifting the spotlight to how its current valuation lines up with fundamentals. See our latest analysis for Campbell's. The recent name change comes against a weaker share price backdrop, with a 7 day share price return showing a 9.02% decline and a 1 year total shareholder return showing a 31.79% decline, suggesting sentiment has...

If you are wondering whether New York Times shares still offer value after a strong run, you will want to look closely at what different valuation methods are saying about the current price. The stock last closed at US$77.99, with returns of 6.9% over 7 days, 7.9% over 30 days, 11.7% year to date, 64.4% over 1 year and 106.5% over 3 years. This naturally raises questions about how much of the story is already reflected in the share price. Recent attention around New York Times has focused on...

Helmerich & Payne’s joint venture Turan Drilling and Engineering recently secured a long-term offshore operations and maintenance contract renewal from BP in the Caspian Sea, covering eight platforms over a firm five-year term with three optional one-year extensions and a potential value above US$1.00 billion. This renewal highlights the company’s growing international service footprint and reinforces the importance of offshore partnerships in complementing its largely onshore-focused...

If you are wondering whether Ovintiv's share price still offers value at current levels, it helps to step back and look at what the market might be pricing in. The stock closed at US$50.58, with returns of 7.8% over the last 7 days, 23.3% over the last 30 days, 24.9% year to date, 20.3% over 1 year, 20.9% over 3 years, and 147.0% over 5 years. Recent news around Ovintiv has largely focused on its position in the US energy sector and how investors are weighing commodity price moves against...

If you are wondering whether Procter & Gamble at around US$160.78 is giving you fair value for a long term consumer staples holding, this article is designed to walk you through that question clearly. The share price return data is mixed, with the stock showing 0.4% over the last week, 7.1% over the last month, 13.4% year to date, 24.6% over 3 years and 47.7% over 5 years, while the 1 year figure stands at a 3.0% decline. Recent commentary around Procter & Gamble has focused on how a large,...

Halozyme Therapeutics (NasdaqGS:HALO) reported a quarterly net loss after recording a major impairment charge. The company outlined plans to actively pursue acquisitions to expand its drug delivery portfolio. These developments come alongside strong revenue growth in the latest quarter. Halozyme Therapeutics, trading at $70.98, is coming off a mixed stretch, with the share price down 10.6% over the past week but up 22.9% over the past year and 56.9% over five years. For investors, the...

Fidelity National Information Services (FIS) is back in focus ahead of its upcoming earnings report, with expectations for year-over-year growth in earnings and revenue, plus fresh hedge fund interest in the oversold stock. See our latest analysis for Fidelity National Information Services. At a share price of $49.13, Fidelity National Information Services has seen a 4.98% 7 day share price return, but a 25.13% decline year to date and a 60.22% drop in 5 year total shareholder return, which...

Granite Construction (NYSE:GVA) has been selected by the Nevada Department of Transportation to provide preconstruction services for the future Interstate 80 East Widening Project. The project focuses on a key stretch of the I-80 corridor, with this phase centered on planning and design rather than full construction. The award underscores Granite Construction's role in large public infrastructure work and its experience with collaborative delivery models. For investors tracking NYSE:GVA,...

In February 2026, IDEXX Laboratories announced that long-serving director M. Anne Szostak will retire from the Board after the 2026 Annual Meeting, with no disagreements cited and the Class III board size reduced upon her departure while overall board size is maintained through the previously announced appointment of Michael G. Erickson, PhD, as a Class II director. This board transition comes as IDEXX benefits from strong recurring revenue, ongoing earnings outperformance, and growing...

Credo Technology Group Holding (CRDO) has drawn fresh attention after raising third quarter fiscal 2026 revenue guidance to US$404 million to US$408 million, along with announcing new PCIe retimer launches and PCI-SIG compliance for its Toucan PCIe 6.0 capable product. See our latest analysis for Credo Technology Group Holding. The raised guidance and PCIe product milestones come after a mixed price patch, with a 1 day share price return of 5.05% decline, a 30 day share price return of 6.83%...

If you are wondering whether Element Solutions at around US$35.44 is still reasonably priced or already looking expensive, this article will walk through what the current numbers suggest about value. The share price has recently been active, with returns of 9.5% over 7 days, 23.5% over 30 days, 36.6% year to date, and 36.7% over the past year. These moves can change how the market views both upside potential and risk. These moves sit against a backdrop of ongoing interest in materials and...

In February 2026, Amkor Technology, Inc. reported fourth-quarter 2025 sales of US$1,888.05 million and net income of US$171.76 million, issued first-quarter 2026 guidance, completed a US$487.5 million follow-on equity offering of 10,000,000 common shares at US$48.75 each, and affirmed a quarterly cash dividend of US$0.08352 per share payable on March 31, 2026. These updates came alongside plans for US$2.5–3.0 billion of 2026 capital expenditures focused on advanced packaging capacity,...

Astera Labs (ALAB) is back in focus after reporting fourth quarter and full year 2025 earnings, issuing first quarter 2026 guidance, announcing a new Israel R&D center, and confirming a CFO transition. See our latest analysis for Astera Labs. The earnings beat, new Israel R&D center and CFO appointment come after a sharp 30 day share price return decline of 23.56% and a year to date share price return decline of 27.78%. However, the 1 year total shareholder return of 53.23% still points to...

If you are wondering whether Birkenstock Holding is fairly priced or offering value right now, this article will walk through what the current numbers actually say about the stock. At a last close of US$40.89, the shares show a 2.7% return over the past 7 days, 3.4% over the last 30 days, and a 2.1% decline year to date, with a 21.1% decline over the past year adding extra interest around where value might sit today. Recent coverage has focused on Birkenstock Holding as a listed footwear...